Kedem enters contract with Corealis Pharma for KDM-1102 supplies
The KDM-1102 drug is a new sublingual formulation of propanolol whose formulation development is now completed and can be produced in large volume. The sublingual formulation is designed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.